The U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with Opioid Use Disorder (OUD).

The reSET-O® app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional, in conjunction with treatment that includes buprenorphine and contingency management. Contingency management is a behavior modification intervention that establishes a connection between new, targeted behavior and the opportunity to obtain a desired reward.

The reSET-O® is an app that can be downloaded directly to a patient’s mobile device after they receive a prescription to do so from their doctor. It is intended to be used while participating in an outpatient OUD treatment program. It can serve as a training, monitoring and reminder tool for health care providers and patients in maintaining an outpatient treatment program. It includes a compliance reward system– such as earning special icons on a prize wheel within the app.


Oceanside Suboxone headed by Dr. Shawn Howland has been trained in the use and implementation of this mobile application. The reSET-O® app has not been shown to decrease illicit drug use or improve abstinence in patients with OUD. With Dr. Howland’s assistance, patients can download the reSET-O® app through the Apple App Store or Google Play Store on their smartphone or tablet. An access code is given to them at the time of prescription.

reSET-O® is typically paid for by fully insured health plans and self-insured employers as either a pharmacy benefit or a medical benefit. Co-payments, co-insurance, and deductibles may apply.

reSET-O ® is not intended to be used as a stand-alone therapy for substance use disorder (SUD). reSET does not replace care by a licensed medical practitioner and is not intended to reduce the amount of face-to-face clinician time. reSET-O ® does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.

For more information on how reSET-O® can help increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician, contact Dr. Shawn Howland at Oceanside Suboxone Treatment located in Providence, Rhode Island.